Apjohn Ventures Fund is a new venture capital firm based in Kalamazoo, Michigan established to invest primarily in early stage life
Business Model:
Revenue: $13.9M
Employees: 2-10
Address: 350 E Michigan Ave
City: Kalamazoo
State: MI
Zip: 49007
Country: US
Apjohn Ventures Fund is a new venture capital firm based in Kalamazoo, Michigan established to invest primarily in early stage life sciences companies across the Midwest. The goal of the Fund is to provide investors with superior financial returns by making equity investments in innovative life sciences companies with sustainable and outstanding growth potential.
Contact Phone:
+12693498999
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2004 | Zystor | Series A | 0 |
6/2010 | CytoPherx | Series B | 11.7M |
1/2012 | CytoPherx | Series C | 34M |
10/2007 | CytoPherx | Series A | 2.5M |
5/2005 | Sierra Oncology | Venture Round | 2.5M |
4/2014 | Sierra Oncology | Series D | 0 |
3/2005 | Sierra Oncology | Venture Round | 1.1M |
11/2016 | Tetra Therapeutics | Series A | 0 |
9/2005 | Kereos | Series B | 0 |
5/2008 | Sierra Oncology | Venture Round | 0 |
9/2006 | RenaMed Biologics | Venture Round | 0 |
8/2006 | Intranasal Therapeutics | Series A | 0 |
11/2003 | Asterand | Series C | 3M |
12/2004 | Sierra Oncology | Venture Round | 775k |
11/2016 | Tetra Discovery | Series A | 0 |
11/2009 | Svelte Medical Systems | Debt Financing | 0 |
3/2009 | Intranasal Therapeutics | Series B | 0 |
11/2016 | Tetra Discovery | Series A | 0 |
11/2016 | Tetra Therapeutics | Series A | 0 |
4/2014 | Sierra Oncology | Series D | 0 |
1/2012 | CytoPherx | Series C | 0 |
6/2010 | CytoPherx | Series B | 0 |
11/2009 | Svelte Medical Systems | Debt Financing | 0 |
3/2009 | Intranasal Therapeutics | Series B | 0 |
5/2008 | Sierra Oncology | Venture Round | 0 |
10/2007 | CytoPherx | Series A | 0 |
9/2006 | RenaMed Biologics | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|